{
  "articles": [
    {
      "id": "article_1769056636339",
      "title": "Frequency-adjusted daratumumab-based regimen versus bortezomib/dexamethasone in newly diagnosed AL amyloidosis: a matched-cohort study.",
      "summary": "In newly diagnosed AL amyloidosis, a frequency-adjusted daratumumab regimen showed promise as an alternative treatment to standard bortezomib/dexamethasone therapy.",
      "url": "https://pubmed.ncbi.nlm.nih.gov/41560662/",
      "source": "PubMed",
      "category": "Clinical Trials",
      "cancer_types": [
        "General"
      ],
      "quality_score": 12,
      "pub_date": "2026-01",
      "added_date": "2026-01-22T04:37:16.339Z"
    }
  ],
  "last_updated": "2026-01-22T04:37:16.339Z",
  "total_count": 1
}